Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
nüm Vapocoolant Spray vs EMLA Cream for Port Access Pain
NCT06023368Phase 4Withdrawn
- Start
- Dec 2023
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ethyl chloride in procedural pain. Planned start Dec 2023; status: withdrawn.
02
Drugs
ethyl chloride
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT06023368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06023368.